[go: up one dir, main page]

LV15614A - 2-(2-okso-3-pirolin-1-il)acetamīdi kā pretkrampju līdzekļi - Google Patents

2-(2-okso-3-pirolin-1-il)acetamīdi kā pretkrampju līdzekļi

Info

Publication number
LV15614A
LV15614A LVP-20-49A LVP2020000049A LV15614A LV 15614 A LV15614 A LV 15614A LV P2020000049 A LVP2020000049 A LV P2020000049A LV 15614 A LV15614 A LV 15614A
Authority
LV
Latvia
Prior art keywords
acetamides
anticonvulsants
pyrolin
oxo
eto
Prior art date
Application number
LVP-20-49A
Other languages
English (en)
Inventor
Līga ZVEJNIECE
Maija Dambrova
Baiba ŠVALBE
Edijs VĀVERS
Grigorijs Veinbergs
Maksims Vorona
Jevgēņijs KUZŅECOVS
Natalja ORLOVA
Ivars KALVIŅŠ
Original Assignee
Latvijas Organiskās Sintēzes Institūts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Latvijas Organiskās Sintēzes Institūts filed Critical Latvijas Organiskās Sintēzes Institūts
Priority to LVP-20-49A priority Critical patent/LV15614A/lv
Priority to CA3183942A priority patent/CA3183942A1/en
Priority to PCT/IB2021/055990 priority patent/WO2022023839A1/en
Publication of LV15614A publication Critical patent/LV15614A/lv
Priority to DKPA202270605A priority patent/DK181768B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
    • C07D207/27—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Izgudrojums attiecas uz jaunu acetamīdu ar formulu (1a-c) iegūšanu un to lietošanu par pretkrampju līdzekļiem, kur: a) R=Ph, R1=Me; b) R=Ph, R1=i-Pr; c) R=EtO, R1=Et.
LVP-20-49A 2020-07-30 2020-07-30 2-(2-okso-3-pirolin-1-il)acetamīdi kā pretkrampju līdzekļi LV15614A (lv)

Priority Applications (4)

Application Number Priority Date Filing Date Title
LVP-20-49A LV15614A (lv) 2020-07-30 2020-07-30 2-(2-okso-3-pirolin-1-il)acetamīdi kā pretkrampju līdzekļi
CA3183942A CA3183942A1 (en) 2020-07-30 2021-07-05 2-(2-oxo-3-pyrolin-1-yl)acetamides as anticonvulsants
PCT/IB2021/055990 WO2022023839A1 (en) 2020-07-30 2021-07-05 2-(2-oxo-3-pyrolin-1-yl)acetamides as anticonvulsants
DKPA202270605A DK181768B1 (en) 2020-07-30 2022-12-13 2-(2-oxo-3-pyrolin-1-yl)acetamides as anticonvulsants

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LVP-20-49A LV15614A (lv) 2020-07-30 2020-07-30 2-(2-okso-3-pirolin-1-il)acetamīdi kā pretkrampju līdzekļi

Publications (1)

Publication Number Publication Date
LV15614A true LV15614A (lv) 2022-02-20

Family

ID=77021675

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-20-49A LV15614A (lv) 2020-07-30 2020-07-30 2-(2-okso-3-pirolin-1-il)acetamīdi kā pretkrampju līdzekļi

Country Status (4)

Country Link
CA (1) CA3183942A1 (lv)
DK (1) DK181768B1 (lv)
LV (1) LV15614A (lv)
WO (1) WO2022023839A1 (lv)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008132142A2 (en) * 2007-04-27 2008-11-06 Ucb Pharma S.A. New heterocyclic derivatives useful for the treatment of cns disorders

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0004297D0 (en) 2000-02-23 2000-04-12 Ucb Sa 2-oxo-1 pyrrolidine derivatives process for preparing them and their uses
EP2147911A1 (en) 2008-07-24 2010-01-27 ZaCh System S.p.A. Process for the preparation of levetiracetam
CA2831830C (en) * 2011-04-18 2017-12-12 Ucb Pharma, S.A. 2-oxo-1-imidazolidinyl imidazothiadiazole derivatives
CN102924357A (zh) * 2011-08-09 2013-02-13 重庆圣华曦药业股份有限公司 奥拉西坦中间体的制备方法
RU2480214C1 (ru) * 2011-09-22 2013-04-27 Валентина Ивановна Ахапкина Состав, обладающий модуляторной активностью с соразмерным влиянием, фармацевтическая субстанция (варианты), применение фармацевтической субстанции, фармацевтическая и парафармацевтическая композиция (варианты), способ получения фармацевтических составов
PT3371150T (pt) 2015-11-03 2021-11-05 Ucb Biopharma Sprl Processo de preparação do brivaracetam
JP2019531323A (ja) * 2016-10-24 2019-10-31 チョンキン ランゼ ファーマスーティカル カンパニー リミテッド （ｒ）−４−ヒドロキシ−２−オキソ−１−ピロリジンアセトアミドの結晶型、調製方法、用途

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008132142A2 (en) * 2007-04-27 2008-11-06 Ucb Pharma S.A. New heterocyclic derivatives useful for the treatment of cns disorders

Also Published As

Publication number Publication date
CA3183942A1 (en) 2022-02-03
DK202270605A9 (en) 2025-01-08
DK181768B1 (en) 2024-12-05
WO2022023839A1 (en) 2022-02-03
DK202270605A1 (en) 2022-12-22

Similar Documents

Publication Publication Date Title
MX2022006783A (es) Nuevos derivados de metilquinazolinona.
UA96314C2 (ru) Замещенные 1-(3-пиридинил)пиразол-4-илуксусные кислоты и их применение в качестве гербицидов и регуляторов роста растений
EA200870193A1 (ru) Цитотоксические агенты, включающие новые производные томаймицина, и их терапевтическое применение
CY1110398T1 (el) Ενωσεις για την αγωγη της δυσλιπιδαιμιας
BR112014003237A2 (pt) compostos de indazol, composições e métodos de uso
CY1109331T1 (el) Παραγωγα αμινοφαινυλιου ως νεοι αναστολεις της αποακετυλασης ιστονης
NO20076479L (no) Nye oksadiazolderivater og anvendelse derav som positive allosteriske metabotropiske modulatorer av glutamatreseptorer
UA109220C2 (uk) Похідні (4-фенілімідазол-2-іл)етиламіну як модулятори натрієвих каналів
PE20080093A1 (es) Inhibidores de la replicacion del virus de la inmunodeficiencia humana
CY1112011T1 (el) Παραγωγα αζαδικυκλο (3.1.0) εξανιου χρησιμα ως ρυθμιστες υποδοχεων d3 ντοπαμινης
HRP20120323T1 (en) Diarylhydantoin compounds
DK2134691T3 (da) Quinolinonderivativer som parp- og tank-inhibitorer
EA201000805A1 (ru) Бис-(сульфониламино)производные в терапии 066
EA200801630A1 (ru) Соединения пиперазина с гербицидным действием
ATE547415T1 (de) Inhibitoren der wechselwirkung zwischen mdm2 und p53
EA201000050A1 (ru) Замещенные бициклолактамные соединения
DK1981871T3 (da) Heterocyclylalkylderivater som hidtil ukendte inhibitorer af histondeacetylase
MX2012000441A (es) Derivados de 1,2,4-tiazolidin-3-ona y uso en el tratamiento del cancer.
CY1114799T1 (el) Παραγωγα τετραϋδροκινολινης για τη θεραπεια διαταραχων μετατραυματικου στρες
NO20076478L (no) Substituerte oksadiazolderivater som positive allosteriske modulatorer av metabotrope glutamatreseptorer
ZA202213152B (en) Novel acid secretion inhibitor and use thereof
EA200802214A1 (ru) 2,4-диаминопиримидины в качестве ингибиторов киназ, участвующих в регуляции клеточного цикла
ATE440833T1 (de) Antithrombotische diamide
DE602004008959D1 (de) Benzoäbüä1,4üdioxepinderivate
EA200801199A1 (ru) Ингибиторы киназы